Pressmeddelanden från Bioretec

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Bioretec Ltd - Managers' transactions - Paavola 15 maj 08:00

Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy 13 maj 13:00

Bioretec clarifies its 2026–2028 financial target regarding the sales margin 08 maj 19:40

Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors 08 maj 13:45

Bioretec Ltd's resolutions of the Annual General Meeting 29 apr 15:40

Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Sp-Rahastoyhtiö)28 apr 15:55

Bioretec Ltd – Manager’s transactions – Stephen Industries Inc Oy 28 apr 14:55

Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Kustaa Poutiainen)28 apr 12:40

Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue 28 apr 12:10

New shares of Bioretec Ltd registered with the trade register 27 apr 15:00

Bioretec Ltd - Manager's transactions - Paavola 24 apr 17:45

Final results of Bioretec Ltd's rights issue 23 apr 15:00

Inside information: Preliminary result of Bioretec Ltd's rights issue 20 apr 15:30

NOTICE OF THE ANNUAL GENERAL MEETING OF BIORETEC LTD 15 apr 11:00

Bioretec Ltd – Manager’s transactions – Stephen Industries Inc Oy 02 apr 14:00

Bioretec Ltd publishes an exemption document relating to its rights issue 27 mar 11:50

Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue 27 mar 10:05

Bioretec Ltd's resolutions of the Extraordinary General Meeting 26 mar 16:50

The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid 24 mar 12:45

Change to the publication date of Business Review: Bioretec publishes January-March 2026 Business Review on 15 May 2026 13 mar 16:15

Bioretec Ltd’s Financial Statements and Annual Report 2025 published 12 mar 15:30

Inside information: Timo Lehtonen takes on a new role at Bioretec as External Executive Advisor and steps down from the management team 10 mar 20:31

Notice of the Extraordinary General Meeting of Bioretec Ltd 10 mar 20:30

Inside information: Bioretec Ltd is planning a rights issue of at least EUR 5 million and up to EUR 15 million with a maximum of 1,500,000,000 new shares 13 feb 08:31

Inside information: Bioretec Ltd's Board of Directors is assessing a potential rights issue in the near future 13 feb 08:30

A year of rebuilding and renewed focus 09 feb 15:30

Bioretec Ltd’s financial statements bulletin for January–December 2025 will be published on February 13, 2026 30 jan 12:45

Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2026 16 jan 16:45

CMS Transitional Pass-Through Payment (TPT) description for HCPCS code C1741 has been revised 15 jan 16:30

Tuukka Paavola appointed as Chief Financial Officer of Bioretec 22 dec 2025 16:30

Bioretec Ltd’s schedule for financial reporting and Annual General Meeting in 2026 16 dec 2025 07:45

Inside information: Bioretec updates its strategy for 2026-2028 and provides new financial targets 14 dec 2025 16:45

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin 04 dec 2025 11:00

Change negotiations completed at Bioretec 13 nov 2025 07:30

Bioretec Ltd’s business review January–September 2025: Strengthening commercial foundations and strategy design 12 nov 2025 11:30

Inside information: Bioretec initiates change negotiations to enance operational efficiency and competitiveness 31 okt 2025 07:30

Correction: Bioretec Ltd’s Half-year report 2025 27 okt 2025 20:14

Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025 27 okt 2025 09:00

Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets 01 okt 2025 14:00

Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US 01 okt 2025 14:00

Bioretec’s RemeOs™ Trauma Screw Approved for Transitional Pass-Through Payment in the U.S.16 sep 2025 18:30

Composition of Bioretec’s Shareholders' Nomination Board 15 sep 2025 16:30

Inside information: Anne-Mari Matikainen appointed as Interim Chief Financial Officer of Bioretec; CFO Johanna Salko to depart before year-end 15 sep 2025 14:15

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register 12 sep 2025 10:00

Inside information: Bioretec updates the commercialization status of RemeOs™ DrillPin 04 sep 2025 14:00

Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board 02 sep 2025 14:15

Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth 28 aug 2025 09:15

Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)27 aug 2025 15:00

Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer 27 aug 2025 12:15

Inside information: Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer 14 aug 2025 07:00

Bioretec Ltd’s Half-year report 2025: Strong support for future growth from a successful rights issue 11 jul 2025 07:00

René Eve appointed as Director of Operations of Bioretec Ltd.27 jun 2025 07:00

Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue 26 jun 2025 15:00

New shares of Bioretec Ltd registered with the trade register 25 jun 2025 10:45

Bioretec Ltd – Managers’ transactions – Stephen Industries Inc Oy 24 jun 2025 17:30

Final results of Bioretec Ltd's successful rights issue 23 jun 2025 11:30

Inside information: Preliminary result of Bioretec Oy's rights issue 10 jun 2025 15:30

Bioretec Ltd – Managers’ transactions – Stephen Industries Inc Oy 04 jun 2025 15:00

Bioretec Ltd publishes an exemption document relating to its rights issue 28 maj 2025 13:00

Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue 20 maj 2025 13:00

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register 15 maj 2025 09:15

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec 15 maj 2025 07:00

Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products 08 maj 2025 17:45

Inside information: Bioretec´s CEO Alan Donze to resign 09 apr 2025 16:15

Bioretec Ltd – Managers’ transactions – Alan Donze 09 apr 2025 16:00

Bioretec Ltd – Managers’ transactions – Justin Barad 09 apr 2025 16:00

Bioretec Ltd – Managers’ transactions – Sarah van Hellenberg Hubar-Fisher 09 apr 2025 16:00

Bioretec Ltd – Managers’ transactions – Kustaa Poutiainen 09 apr 2025 16:00

Bioretec Ltd – Managers’ transactions – Michael Piccirillo 09 apr 2025 16:00

Bioretec Ltd – Managers’ transactions – Päivi Malinen 09 apr 2025 16:00

Bioretec Ltd – Managers’ transactions – Antti Vasara 21 mar 2025 14:00

Bioretec Ltd's Board of Directors has decided on a new option program for the CEO 21 mar 2025 13:30

Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors 14 mar 2025 18:30

Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)14 mar 2025 18:00

Bioretec Ltd’s Annual Report 2024 published 14 mar 2025 08:00

New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register 07 mar 2025 08:00

Mirva Ekman appointed to Bioretec's Management Team as Quality Director 28 feb 2025 11:30

NOTICE OF ANNUAL GENERAL MEETING OF BIORETEC LTD 14 feb 2025 17:30

CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec 14 feb 2025 16:00

Bioretec Ltd’s Financial Statements 2024 published 14 feb 2025 07:00

Bioretec Ltd’s financial statements bulletin 2024: Foundation for future growth in 2024 – CE mark received in January 2025 31 jan 2025 18:45

Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe 30 jan 2025 09:30

Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2025 16 dec 2024 17:15

Bioretec Ltd’s schedule for financial reporting in 2025 12 dec 2024 17:15

The Finnish Financial Supervisory Authority has imposed a penalty payment on a member of Bioretec's Board of Directors for late notification of managers' transactions 29 nov 2024 12:30

Correction: Bioretec Ltd – Managers’ transactions – Stephen Industries Inc Oy 29 nov 2024 06:45

Bioretec Ltd – Managers’ transactions – Poutiainen 28 nov 2024 15:30

Bioretec Ltd: 3,000,000 new shares registered with the trade register 27 nov 2024 21:15

Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million 27 nov 2024 17:30

Inside information: Bioretec Ltd launches an accelerated book-building process to raise approximately EUR 5 million through a private placement of new shares 22 nov 2024 08:30

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market 20 nov 2024 14:30

The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement 14 nov 2024 07:45

Bioretec Ltd’s business review January–September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage 04 okt 2024 13:31

Inside information: Bioretec updates its financial targets 04 okt 2024 13:30

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage 20 sep 2024 08:00

Bioretec’s Shareholders' Nomination Board appointed 15 aug 2024 07:00

Bioretec Ltd’s half-year report January–June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results 27 jun 2024 21:30

Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization 19 jun 2024 20:00

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures 18 jun 2024 08:00

Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a member of the Management Team